Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Yao Shi Fu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5855-4706; OpenAlex author ID A5028833857. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. 3-Indoleacetic Acid-Modified Chondroitin Sulfate-Mediated Paclitaxel Nanocrystal Assembly for the Treatment of Pancreatic Cancer. Last author DOI 10.1021/acsami.4c19450↗
  2. Hierarchical assembly of hyaluronan coated albumin nanoparticles for pancreatic cancer chemoimmunotherapy. Last author DOI 10.1039/c9nr03684a↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhirong Zhang · 2 shared papers, 2019–2025 · strength 0.36
  2. Yueting Zhu · 1 shared paper, 2025 · strength 0.27
  3. Weiyuan John Kao · 1 shared paper, 2019 · strength 0.10
  4. Ying Hu · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.